TY - JOUR
T1 - Effects of N-glycosylation on the transport kinetics of organic anion transporting polypeptide (OATP) 1B1
AU - Tanino, Manami
AU - Tsujii, Kazunari
AU - Kataoka, Hiroki
AU - Takahashi, Riho
AU - Imaoka, Ayuko
AU - Akiyoshi, Takeshi
AU - Ohtani, Hisakazu
N1 - Publisher Copyright:
© 2026 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0/
PY - 2026/4
Y1 - 2026/4
N2 - Organic anion transporting polypeptide (OATP) 1B1 is crucial for hepatic drug uptake. Three N-glycosylation sites, Asn134, Asn503, and Asn516, have been identified, and substituting the amino acid at these sites with glutamine reduces the expression of the OATP1B1 protein on the plasma membrane. However, the effects of disrupted N-glycosylation on the transport kinetics of OATP1B1 molecule remained uninvestigated. This study quantitatively analyzed the impact of N-glycosylation modifications on the intrinsic transport activity of OATP1B1.We established artificial mutant OATP1B1-expressing HEK293 cell lines with substitution of asparagine at one or multiple N-glycosylation sites with glutamine. The change in molecular weight of OATP1B1 protein in the plasma membrane fraction was assessed by Western blotting. OATP1B1 transport activity was evaluated by measuring 2′,7′-dichlorofluorescein (DCF) uptake to determine the Michaelis constant (Km) and maximum transport rate (Vmax). The Vmax value per OATP1B1 molecule (Vmax,c) was calculated by dividing Vmax by the expression level of OATP1B1 in the plasma membrane fraction quantified by LC-MS/MS.Western blotting revealed that all mutant OATP1B1 proteins showed lower molecular weights than the wild-type. Among mutation sites, Asn134 was confirmed to be the primary glycosylation site, as reported previously. Regarding transport activity, the Km value of the Asn134/503/516Gln mutant decreased to 0.3-fold that of the wild-type. However, its Vmax,c value decreased to 0.2-fold that of the wild-type. Thus, N-glycosylation of OATP1B1 is not only important for the plasma membrane localization but also for transport activity.
AB - Organic anion transporting polypeptide (OATP) 1B1 is crucial for hepatic drug uptake. Three N-glycosylation sites, Asn134, Asn503, and Asn516, have been identified, and substituting the amino acid at these sites with glutamine reduces the expression of the OATP1B1 protein on the plasma membrane. However, the effects of disrupted N-glycosylation on the transport kinetics of OATP1B1 molecule remained uninvestigated. This study quantitatively analyzed the impact of N-glycosylation modifications on the intrinsic transport activity of OATP1B1.We established artificial mutant OATP1B1-expressing HEK293 cell lines with substitution of asparagine at one or multiple N-glycosylation sites with glutamine. The change in molecular weight of OATP1B1 protein in the plasma membrane fraction was assessed by Western blotting. OATP1B1 transport activity was evaluated by measuring 2′,7′-dichlorofluorescein (DCF) uptake to determine the Michaelis constant (Km) and maximum transport rate (Vmax). The Vmax value per OATP1B1 molecule (Vmax,c) was calculated by dividing Vmax by the expression level of OATP1B1 in the plasma membrane fraction quantified by LC-MS/MS.Western blotting revealed that all mutant OATP1B1 proteins showed lower molecular weights than the wild-type. Among mutation sites, Asn134 was confirmed to be the primary glycosylation site, as reported previously. Regarding transport activity, the Km value of the Asn134/503/516Gln mutant decreased to 0.3-fold that of the wild-type. However, its Vmax,c value decreased to 0.2-fold that of the wild-type. Thus, N-glycosylation of OATP1B1 is not only important for the plasma membrane localization but also for transport activity.
KW - Glycosylation
KW - Pharmacokinetics
KW - Post-translational modification
KW - SLCO1B1
KW - Transporter
UR - https://www.scopus.com/pages/publications/105032236643
UR - https://www.scopus.com/pages/publications/105032236643#tab=citedBy
U2 - 10.1016/j.bbamem.2026.184509
DO - 10.1016/j.bbamem.2026.184509
M3 - Article
C2 - 41707902
AN - SCOPUS:105032236643
SN - 0005-2736
VL - 1868
JO - Biochimica et Biophysica Acta - Biomembranes
JF - Biochimica et Biophysica Acta - Biomembranes
IS - 2
M1 - 184509
ER -